{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:45:59Z","timestamp":1762854359475,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.gofs.2021.03.029","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T20:52:24Z","timestamp":1616273544000},"page":"448-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Traitement hormonal de la m\u00e9nopause et cognition. RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi"],"prefix":"10.1016","volume":"49","author":[{"given":"G.","family":"Andr\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.gofs.2021.03.029_bib0290","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1212\/WNL.53.9.1992","article-title":"Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group","volume":"53","author":"Andersen","year":"1999","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.gofs.2021.03.029_bib0295","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1532-5415.2012.04056.x","article-title":"Burden of Alzheimer's disease-related mortality in the United States, 1999\u20132008","volume":"60","author":"Moschetti","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.gofs.2021.03.029_bib0300","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2011.08.002","article-title":"Neuroprotective actions of estradiol revisited","volume":"22","author":"Azcoitia","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.029_bib0305","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jnr.10811","article-title":"Estrogen and cognition: applying preclinical findings to clinical perspectives","volume":"74","author":"Gibbs","year":"2003","journal-title":"J Neurosci Res"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0310","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.brainresrev.2005.01.009","article-title":"Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs","volume":"49","author":"Zhao","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"issue":"17","key":"10.1016\/j.gofs.2021.03.029_bib0315","doi-asserted-by":"crossref","first-page":"e2005","DOI":"10.1212\/WNL.0000000000007326","article-title":"Reproductive period and risk of dementia in a diverse cohort of health care members","volume":"92","author":"Gilsanz","year":"2019","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.029_bib0320","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.029_bib0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000314681","article-title":"Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study","volume":"30","author":"Phung","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"14","key":"10.1016\/j.gofs.2021.03.029_bib0330","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1212\/WNL.0b013e31828ab370","article-title":"Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores","volume":"80","author":"Kaffashian","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.029_bib0335","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction\u00a0\u2013\u00a0The disregarded partner of Alzheimer's disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimer Dement"},{"issue":"13","key":"10.1016\/j.gofs.2021.03.029_bib0340","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0345","first-page":"CD002229","article-title":"Hormone therapy for preventing cardiovascular disease in postmenopausal women","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.029_bib0350","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.029_bib0355","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study","volume":"75","author":"Matsuzaki","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.029_bib0360","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/me.2008-0366","article-title":"Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination","volume":"23","author":"Berrodin","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0365","doi-asserted-by":"crossref","first-page":"e89095","DOI":"10.1371\/journal.pone.0089095","article-title":"Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia","volume":"9","author":"Rasgon","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.029_bib0370","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.psyneuen.2010.08.002","article-title":"Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD","volume":"36","author":"Silverman","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.gofs.2021.03.029_bib0375","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1210\/en.2010-0005","article-title":"Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo","volume":"151","author":"Liu","year":"2010","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.029_bib0380","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.54.2.295","article-title":"Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial","volume":"54","author":"Henderson","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0385","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.284.3.307","article-title":"Estrogen as a treatment for Alzheimer disease","volume":"284","author":"Mulnard","year":"2000","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.029_bib0390","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.285.11.1489","article-title":"Hormone replacement therapy and cognition: systematic review and meta-analysis","volume":"285","author":"LeBlanc","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0395","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(00)00410-3","article-title":"The nature of the effect of female gonadal hormone replacement therapy on cognitive function in postmenopausal women: a meta-analysis","volume":"101","author":"Hogervorst","year":"2000","journal-title":"Neuroscience"},{"issue":"24","key":"10.1016\/j.gofs.2021.03.029_bib0400","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.gofs.2021.03.029_bib0405","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0410","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.gofs.2021.03.029_bib0415","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.gofs.2021.03.029_bib0420","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.029_bib0425","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jnnp.2003.024927","article-title":"Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age","volume":"76","author":"Henderson","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.029_bib0430","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.22239","article-title":"Timing of hormone therapy and dementia: the critical window theory revisited","volume":"69","author":"Whitmer","year":"2011","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1016\/j.gofs.2021.03.029_bib0435","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1212\/WNL.0b013e318271f823","article-title":"Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study","volume":"79","author":"Shao","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.029_bib0440","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0000000000003696","article-title":"Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study","volume":"88","author":"Imtiaz","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0445","first-page":"870","article-title":"Lower death risk for vascular dementia than for Alzheimer's disease with postmenopausal hormone therapy users","volume":"102","author":"Mikkola","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gofs.2021.03.029_bib0450","doi-asserted-by":"crossref","first-page":"l665","DOI":"10.1136\/bmj.l665","article-title":"Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study","volume":"364","author":"Savolainen-Peltonen","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2021.03.029_bib0455","doi-asserted-by":"crossref","first-page":"l877","DOI":"10.1136\/bmj.l877","article-title":"Menopausal hormone therapy and cognition","volume":"364","author":"Maki","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.029_bib0460","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2217\/17455057.3.2.173","article-title":"Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women","volume":"3","author":"Yesufu","year":"2007","journal-title":"Women Health"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.029_bib0465","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archneur.1995.00540290075020","article-title":"The \u2018preclinical phase\u2019 of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort","volume":"52","author":"Linn","year":"1995","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.029_bib0470","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1212\/01.WNL.0000163773.21794.0B","article-title":"Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years","volume":"64","author":"Tierney","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.029_bib0475","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1191\/1740774504cn040oa","article-title":"The Women's Health Initiative Study of Cognitive Aging (WHISCA):a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline","volume":"1","author":"Resnick","year":"2004","journal-title":"Clin Trials"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.029_bib0480","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect","volume":"91","author":"Resnick","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.gofs.2021.03.029_bib0485","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1210\/jc.2009-1340","article-title":"Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy","volume":"94","author":"Resnick","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.029_bib0490","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9343(02)01270-6","article-title":"Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen\/progestin Replacement Study","volume":"113","author":"Grady","year":"2002","journal-title":"Am J Med"},{"issue":"15","key":"10.1016\/j.gofs.2021.03.029_bib0495","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jamainternmed.2013.7727","article-title":"Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years","volume":"173","author":"Espeland","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"21","key":"10.1016\/j.gofs.2021.03.029_bib0500","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/WNL.0b013e3181c34b0c","article-title":"Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study","volume":"73","author":"Ryan","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.029_bib0505","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neurobiolaging.2010.10.007","article-title":"Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline","volume":"33","author":"Kang","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.029_bib0510","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.gme.0000191204.38664.61","article-title":"Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study","volume":"13","author":"MacLennan","year":"2006","journal-title":"Menopause"},{"issue":"21","key":"10.1016\/j.gofs.2021.03.029_bib0515","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/WNL.0b013e3181a71193","article-title":"Effects of the menopause transition and hormone use on cognitive performance in midlife women","volume":"72","author":"Greendale","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0520","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/13697130903370316","article-title":"Postmenopausal hormone therapy and cognition: effects of timing and treatment type","volume":"13","author":"Khoo","year":"2010","journal-title":"Climacteric"},{"issue":"13","key":"10.1016\/j.gofs.2021.03.029_bib0525","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/01.wnl.0000277275.42504.93","article-title":"Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial","volume":"69","author":"Maki","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.029_bib0530","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.10.6.1051","article-title":"Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone","volume":"10","author":"Adams","year":"1990","journal-title":"Arteriosclerosis"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.029_bib0535","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.ATV.17.1.217","article-title":"Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis","volume":"17","author":"Adams","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.029_bib0540","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.ATV.15.7.827","article-title":"Regression of atherosclerosis in female monkeys","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.029_bib0545","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1447-0756.2010.01214.x","article-title":"Estrogen + progestin therapy and cognition: a randomized placebo-controlled double-blind study","volume":"36","author":"Alhola","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.029_bib0550","first-page":"238","article-title":"Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients","volume":"51","author":"Linzmayer","year":"2001","journal-title":"Arzneimittel-Forschung"},{"issue":"7","key":"10.1016\/j.gofs.2021.03.029_bib0555","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1212\/WNL.0000000000002980","article-title":"Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis","volume":"87","author":"Henderson","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.029_bib0560","doi-asserted-by":"crossref","first-page":"e1001833","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-Cognitive and Affective Study","volume":"12","author":"Gleason","year":"2015","journal-title":"PLoS Med"},{"issue":"16","key":"10.1016\/j.gofs.2021.03.029_bib0565","doi-asserted-by":"crossref","first-page":"e1404","DOI":"10.1212\/WNL.0000000000005325","article-title":"Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial","volume":"90","author":"Kantarci","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.gofs.2021.03.029_bib0285","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-160258","article-title":"Early postmenopausal transdermal 17beta-estradiol therapy and amyloid-beta deposition","volume":"53","author":"Kantarci","year":"2016","journal-title":"J Alzheimer Dis"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:41:05Z","timestamp":1762854065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718921000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2468718921000817"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.029","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement hormonal de la m\u00e9nopause et cognition. RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}